1. Examination of Combined Treatment of Ginsenoside Rg3 and 5-Fluorouracil in Lung Adenocarcinoma Cells
    Kuizhong Shan et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
  2. Knockdown of SNORA47 Inhibits the Tumorigenesis of NSCLC via Mediation of PI3K/Akt Signaling Pathway
    Huiqing Yu et al, 2021, Frontiers in Oncology CrossRef
  3. Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications
    Lei Wu et al, 2024, Current Topics in Medicinal Chemistry CrossRef
  4. Research progress of ginseng in the treatment of gastrointestinal cancers
    Baoyi Ni et al, 2022, Frontiers in Pharmacology CrossRef
  5. Ginsenoside Rg3 Induces Low Expression of lncRNA ATXN8OS to Inhibit Colon Cancer Metastasis
    null Jun Wang et al, 2023, Russian Journal of Bioorganic Chemistry CrossRef
  6. Unraveling the Structure-Dependent Inhibitory Effects of Ginsenoside Series Compounds on Human Cytochrome P450 1B1
    Tingting Zhao et al, 2022, Current Drug Metabolism CrossRef
  7. Dual PI3K/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU
    Ziyuan Zhong et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  8. Ginsenosides: an immunomodulator for the treatment of colorectal cancer
    Jianan Qian et al, 2024, Frontiers in Pharmacology CrossRef
  9. Role of Ginseng, Quercetin, and Tea in Enhancing Chemotherapeutic Efficacy of Colorectal Cancer
    Linxian Zhao et al, 2022, Frontiers in Medicine CrossRef
  10. The Effect of Shenyi Capsule on Non-Small-Cell Lung Cancer Combined with Chemotherapy from the Yin-Yang Perspective
    Zhixing Cai et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  11. Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer
    Xiao Luo et al, 2021, Aging CrossRef
  12. Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line
    Ömer Faruk KIRLANGIÇ et al, 2022, Turkish Journal of Pharmaceutical Sciences CrossRef
  13. KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer
    Yu Zheng et al, 2023, Cancer Biology & Therapy CrossRef
  14. Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation
    Shanbo Ma et al, 2024, Frontiers in Pharmacology CrossRef
  15. Specific gut microbiome signature predicts hepatitis B virus-related hepatocellular carcinoma patients with microvascular invasion
    Yu-Chong Peng et al, 2023, Annals of Medicine CrossRef
  16. Natural products‐based antiangiogenic agents: New frontiers in cancer therapy
    Tiago Azevedo et al, 2024, Food Frontiers CrossRef